The Rovati family, which has owned the research center Rottapharm since 2014, announced the intention to divest the laboratories. At the same time, it informed the...
Evotec shares are showing a strong performance, as the price increased by 5.15% this week. The company is expanding its activities in the field of gene...
The pharmaceutical and biotechnology industry managers were invited to visit the White House, by the U.S. president, to discuss the development of possible strategies for the...
The shares of Lysogene, a biopharmaceutical company, have risen by more than 50% thanks to the granted "Fast Track" designation to its investigational therapy LYS-SAF302 for...
The shareholders and founders of “Biogenera”, a medium-sized biotech company, signed an agreement with “Life Care Capital”. Biogenera is a company that has created an internationally...
Genesis Biomed, a company focused on consultancy in the biomedical sector, is bidding hard in the medical industry. Genesis Biomed, directed by Josep Lluís Falcó, intends...
Regeneron Pharmaceuticals Inc shares rebounded as investors found out about collaboration partner Sanofi SA’s liquidation of its Regeneron stake. The two companies also plan to restructure...
The Sartorius Group, a leading international partner of life science research and the biopharmaceutical industry, signed an agreement to acquire a majority stake in the Israeli...
Evotec and MorphoSys, two German biotech companies recorded substantial profits. The MorphoSys shares gained 3.2%, making it the second strongest MDAX stock of the day, after...
Novartis is planning to buy U.S. East Coast biotechnology company The Medicines in New Jersey and close the transaction in 2020. Novartis has offered $85 per...